
About Asphalion
Asphalion is a Healthcare company based in Barcelona (Spain) founded in 2000. Scientific and regulatory support for drug development is offered globally. Its focus areas include Biopharma Outsourcing, Consulting and Regulatory Affairs.
Company details
ASPHALION is a global scientific and regulatory affairs company offering drug development and regulatory affairs services to pharma, biotech, and medical device companies. The company claims that its consultants have significant expertise in working with EU agencies (EMA and NCA) for development and implementation of new regulatory standards.They offer their services right from the early development phase to right until the post-commercialization phase. They can offer their services for both FDA and EMA registration and approvals. Their services include regulatory support during development, writing and authoring, submission management, eSubmission, among others.
- Headquarters Barcelona, Spain
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website asphalion.com
- Social LinkedIn X Facebook YouTube
- Latest Funding Round$397.24K (USD), Grant
Dec 2021
- Investors
Apps and channels of Asphalion
its YouTube channel Asphalion has 421 subscribers and 30 videos.
Videos from Asphalion
The most watched videos on Asphalion's YouTube channel, Asphalion (421 subscribers). Click a video to play it here.
More on Asphalion.
Funding Insights of Asphalion
- Total Rounds 11
- Last Round Grant β $397,237
- First Round $298,650
(Jan 2016)
- Investors Count 1
Latest 10 of 11 funding rounds of Asphalion with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2021 | $397,237 | Grant | β | β | |
| Sep 2021 | $88,857 | Grant | β | β | |
| May 2021 | $284,749 | Grant | β | β | |
| Apr 2021 | $262,717 | Grant | β | β | |
| Mar 2021 | $355,249 | Grant | β | β | |
| Dec 2020 | $209,657 | Grant | β | β | |
| Jan 2020 | $356,902 | Grant | β | β | |
| Jan 2019 | $355,323 | Grant | β | β | |
| Oct 2017 | $360,945 | Grant | β | β | |
| Jan 2017 | $184,204 | Grant | β | β |
1 investors in total: 1 institutional.
Investors in Asphalion
Asphalion has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Asphalion
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Asphalion
20 people are tracked at Asphalion (14 in leadership, 6 in team).
| Name | Role | Group |
|---|---|---|
Talyta Carteano | Medical Devices Director | Leadership |
Laura Eder Azanza | Drug Safety Associate Director & Asphalion Deputy EU QPPV | Leadership |
Consol Bozzo | Regulatory Affairs Director | Leadership |
Lidia Cánovas | General Manager, Regulatory Affairs | Leadership |
Michael Schaub | Regulatory Affairs & Munich Office Director and Director, Marketing & Business Development | Leadership |
André Mota | Regulatory Affairs & Madrid Office Director | Leadership |
Núria Coderch | Scientific Regulatory Affairs Director | Leadership |
Vicente Tur | Regulatory Affairs Director | Leadership |
Núria Romero | Managing Director | Leadership |
Carme Ulla | Quality Assurance & Regulatory Affairs Director | Leadership |
Ester Caravaca | People Partner/ People Manager | Leadership |
Izabela Bedziak | Scientific & Regulatory Associate Director | Leadership |
Ivette Camarasa | Regulatory Affairs Director | Leadership |
Cristina González | Quality Assurance Associate Director | Leadership |
Montse Sedano Gil | Invoicing And Project Support Manage | Team |
Lidia Molins Olivé | Marketing Manager | Team |
Vanessa Brambilla | Senior Regulatory Affairs Specialist | Team |
Nuria García Pazos | Regulatory Affairs Senior Consultant | Team |
Sergio Veiga | Scientific And Regulatory Affairs Senior Officer | Team |
Natalia Carolina Oviedo | Medtech Scientific & Regulatory Affairs Officer | Team |
Complete people profiles for Asphalion
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Asphalion
3 dated milestones of Asphalion across 21 years, from founding to its latest funding, stage changes and deals.
- Founded Asphalion is founded.
- Funding First funding round of $299K.
- Funding Latest funding round, Grant, of $397K.
Web traffic of Asphalion
The website of Asphalion (asphalion.com) receives about 4.9K visits a month.
- Monthly visits4.9K
▼ 65.4% vs previous month
Websites whose visitors overlap most with Asphalion. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
navarrahealthcluster.com | navarrahealthcluster.com | 100% | #2,621,394 | β |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Asphalion
Asphalion was founded in 2000 and raised its 1st funding round 16 years after it was founded.
Asphalion is headquartered in Barcelona, Spain. It is registered at Barcelona, Catalonia, Spain.
ASPHALION is a global scientific and regulatory affairs company offering drug development and regulatory affairs services to pharma, biotech, and medical device companies. The company claims that its consultants have significant expertise in working with EU agencies (EMA and NCA) for development and implementation of new regulatory standards.They offer their services right from the early development phase to right until the post-commercialization phase. They can offer their services for both FDA and EMA registration and approvals. Their services include regulatory support during development, writing and authoring, submission management, eSubmission, among others.
Asphalion has 1 investor. Key investors include European Union.